Bullous Pemphigoid - Pipeline Review, H2 2016 - Key Vendors are iCo Therapeutics Inc, Immungenetics AG, True North Therapeutics & TxCell SA - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Bullous Pemphigoid - Pipeline Review, H2 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Bullous Pemphigoid, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bullous Pemphigoid and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • iCo Therapeutics Inc.
  • Immungenetics AG
  • True North Therapeutics Inc
  • TxCell SA

Key Topics Covered:

  1. Introduction
  2. Bullous Pemphigoid Overview
  3. Therapeutics Development
  4. Pipeline Products for Bullous Pemphigoid - Overview
  5. Pipeline Products for Bullous Pemphigoid - Comparative Analysis
  6. Bullous Pemphigoid - Therapeutics under Development by Companies
  7. Bullous Pemphigoid - Therapeutics under Investigation by Universities/Institutes
  8. Bullous Pemphigoid - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Bullous Pemphigoid - Products under Development by Companies
  13. Bullous Pemphigoid - Products under Investigation by Universities/Institutes
  14. Bullous Pemphigoid - Companies Involved in Therapeutics Development

For more information about this report visit http://www.researchandmarkets.com/research/vfrfz4/bullous

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Dermatological Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Dermatological Drugs